• Return to Headlines

After Yesterday's Decline of 1.52%, Pacira Pharmaceu Offers Investors Better Value

By Nick Russo

Pacira Pharmaceu (NYSE:PCRX) traded in a range yesterday that spanned from a low of $35.40 to a high of $36.75. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $35.75 on volume of 309,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

In the past 52 weeks, shares of Pacira Pharmaceu have traded between a low of $29.95 and a high of $58.95 and are now at $35.70, which is 19% above that low price. The 200-day and 50-day moving averages have moved 0.46% lower and 1.65% lower over the past week, respectively.

SmarTrend recommended that its subscribers protect gains by selling shares of Pacira Pharmaceu on July 25th, 2017 by issuing a Downtrend alert when the shares were trading at $42.67. Since that call, shares of Pacira Pharmaceu have fallen 15.2%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: rebounders pacira pharmaceu

Ticker(s): PCRX